UPADACITINIB EFFECTIVELY LIMITS IL-23 DRIVEN INFLAMMATION AT THE ENTHESIS BY INHIBITING T CELL STAT1 PHOSPHORYLATION, IL-17A AND TNFA PRODUCTIONS. Giryes,C. Bridgewood,C. Wong,T. Macleod,D. McgonagleANNALS OF THE RHEUMATIC DISEASES（2022）引用 0|浏览3暂无评分AI 理解论文溯源树样例生成溯源树，研究论文发展脉络Chat Paper正在生成论文摘要
